New hope for liver cancer patients with TIPS: which chemoembolization works better?
NCT ID NCT07322848
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 10 times
Summary
This study compares two types of chemoembolization (DEB-TACE vs cTACE) in 206 liver cancer patients whose cancer has spread beyond standard transplant criteria and who have previously had a TIPS procedure to manage complications of cirrhosis. The goal is to see which method improves survival and quality of life with fewer side effects. Participants are randomly assigned to one of the two treatments and followed for up to 24 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiiated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510080, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.